nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefotetan—ALB—Fluorouracil—head and neck cancer	0.693	1	CbGbCtD
Cefotetan—Superinfection—Fluorouracil—head and neck cancer	0.0378	0.123	CcSEcCtD
Cefotetan—Phlebitis—Vinblastine—head and neck cancer	0.011	0.0358	CcSEcCtD
Cefotetan—Pancytopenia—Vinblastine—head and neck cancer	0.00778	0.0253	CcSEcCtD
Cefotetan—Pancytopenia—Hydroxyurea—head and neck cancer	0.0071	0.0231	CcSEcCtD
Cefotetan—Neutropenia—Hydroxyurea—head and neck cancer	0.00699	0.0227	CcSEcCtD
Cefotetan—Agranulocytosis—Vinblastine—head and neck cancer	0.00682	0.0222	CcSEcCtD
Cefotetan—Haemoglobin—Vinblastine—head and neck cancer	0.00659	0.0214	CcSEcCtD
Cefotetan—Haemorrhage—Vinblastine—head and neck cancer	0.00656	0.0213	CcSEcCtD
Cefotetan—Blood bilirubin increased—Docetaxel—head and neck cancer	0.00654	0.0213	CcSEcCtD
Cefotetan—Haemoglobin—Hydroxyurea—head and neck cancer	0.00601	0.0196	CcSEcCtD
Cefotetan—Haemorrhage—Hydroxyurea—head and neck cancer	0.00598	0.0195	CcSEcCtD
Cefotetan—Colitis—Docetaxel—head and neck cancer	0.00594	0.0193	CcSEcCtD
Cefotetan—Eosinophilia—Fluorouracil—head and neck cancer	0.00533	0.0173	CcSEcCtD
Cefotetan—Phlebitis—Docetaxel—head and neck cancer	0.00521	0.017	CcSEcCtD
Cefotetan—Leukopenia—Vinblastine—head and neck cancer	0.00511	0.0166	CcSEcCtD
Cefotetan—Pancytopenia—Fluorouracil—head and neck cancer	0.00511	0.0166	CcSEcCtD
Cefotetan—Convulsion—Vinblastine—head and neck cancer	0.00495	0.0161	CcSEcCtD
Cefotetan—Discomfort—Vinblastine—head and neck cancer	0.0048	0.0156	CcSEcCtD
Cefotetan—Leukopenia—Hydroxyurea—head and neck cancer	0.00466	0.0152	CcSEcCtD
Cefotetan—Thrombocytopenia—Vinblastine—head and neck cancer	0.00456	0.0148	CcSEcCtD
Cefotetan—Convulsion—Hydroxyurea—head and neck cancer	0.00451	0.0147	CcSEcCtD
Cefotetan—Agranulocytosis—Fluorouracil—head and neck cancer	0.00448	0.0146	CcSEcCtD
Cefotetan—Discomfort—Hydroxyurea—head and neck cancer	0.00438	0.0142	CcSEcCtD
Cefotetan—Haemoglobin—Fluorouracil—head and neck cancer	0.00433	0.0141	CcSEcCtD
Cefotetan—Haemorrhage—Fluorouracil—head and neck cancer	0.00431	0.014	CcSEcCtD
Cefotetan—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00416	0.0135	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.00405	0.0132	CcSEcCtD
Cefotetan—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00381	0.0124	CcSEcCtD
Cefotetan—Pancytopenia—Docetaxel—head and neck cancer	0.00369	0.012	CcSEcCtD
Cefotetan—Abdominal pain—Vinblastine—head and neck cancer	0.00368	0.012	CcSEcCtD
Cefotetan—Neutropenia—Docetaxel—head and neck cancer	0.00363	0.0118	CcSEcCtD
Cefotetan—Hypersensitivity—Vinblastine—head and neck cancer	0.00343	0.0112	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.00343	0.0112	CcSEcCtD
Cefotetan—Body temperature increased—Hydroxyurea—head and neck cancer	0.00336	0.0109	CcSEcCtD
Cefotetan—Leukopenia—Fluorouracil—head and neck cancer	0.00336	0.0109	CcSEcCtD
Cefotetan—Convulsion—Fluorouracil—head and neck cancer	0.00325	0.0106	CcSEcCtD
Cefotetan—Agranulocytosis—Docetaxel—head and neck cancer	0.00323	0.0105	CcSEcCtD
Cefotetan—Diarrhoea—Vinblastine—head and neck cancer	0.00319	0.0104	CcSEcCtD
Cefotetan—Discomfort—Fluorouracil—head and neck cancer	0.00315	0.0103	CcSEcCtD
Cefotetan—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00313	0.0102	CcSEcCtD
Cefotetan—Haemoglobin—Docetaxel—head and neck cancer	0.00312	0.0102	CcSEcCtD
Cefotetan—Haemorrhage—Docetaxel—head and neck cancer	0.00311	0.0101	CcSEcCtD
Cefotetan—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00306	0.00995	CcSEcCtD
Cefotetan—Thrombocytopenia—Fluorouracil—head and neck cancer	0.003	0.00974	CcSEcCtD
Cefotetan—Vomiting—Vinblastine—head and neck cancer	0.00296	0.00964	CcSEcCtD
Cefotetan—Erythema multiforme—Docetaxel—head and neck cancer	0.00294	0.00956	CcSEcCtD
Cefotetan—Diarrhoea—Hydroxyurea—head and neck cancer	0.00291	0.00946	CcSEcCtD
Cefotetan—Nausea—Vinblastine—head and neck cancer	0.00277	0.009	CcSEcCtD
Cefotetan—Vomiting—Hydroxyurea—head and neck cancer	0.0027	0.00879	CcSEcCtD
Cefotetan—Rash—Hydroxyurea—head and neck cancer	0.00268	0.00872	CcSEcCtD
Cefotetan—Dermatitis—Hydroxyurea—head and neck cancer	0.00268	0.00871	CcSEcCtD
Cefotetan—Nausea—Hydroxyurea—head and neck cancer	0.00252	0.00821	CcSEcCtD
Cefotetan—Urticaria—Fluorouracil—head and neck cancer	0.00243	0.00791	CcSEcCtD
Cefotetan—Leukopenia—Docetaxel—head and neck cancer	0.00242	0.00788	CcSEcCtD
Cefotetan—Body temperature increased—Fluorouracil—head and neck cancer	0.00242	0.00787	CcSEcCtD
Cefotetan—Convulsion—Docetaxel—head and neck cancer	0.00234	0.00762	CcSEcCtD
Cefotetan—Hypersensitivity—Fluorouracil—head and neck cancer	0.00225	0.00733	CcSEcCtD
Cefotetan—Anaphylactic shock—Docetaxel—head and neck cancer	0.00221	0.00718	CcSEcCtD
Cefotetan—Pruritus—Fluorouracil—head and neck cancer	0.00216	0.00704	CcSEcCtD
Cefotetan—Thrombocytopenia—Docetaxel—head and neck cancer	0.00216	0.00703	CcSEcCtD
Cefotetan—Diarrhoea—Fluorouracil—head and neck cancer	0.00209	0.00681	CcSEcCtD
Cefotetan—Vomiting—Fluorouracil—head and neck cancer	0.00195	0.00633	CcSEcCtD
Cefotetan—Rash—Fluorouracil—head and neck cancer	0.00193	0.00627	CcSEcCtD
Cefotetan—Dermatitis—Fluorouracil—head and neck cancer	0.00193	0.00627	CcSEcCtD
Cefotetan—Nausea—Fluorouracil—head and neck cancer	0.00182	0.00591	CcSEcCtD
Cefotetan—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00181	0.00587	CcSEcCtD
Cefotetan—Abdominal pain—Docetaxel—head and neck cancer	0.00175	0.00568	CcSEcCtD
Cefotetan—Body temperature increased—Docetaxel—head and neck cancer	0.00175	0.00568	CcSEcCtD
Cefotetan—Hypersensitivity—Docetaxel—head and neck cancer	0.00163	0.00529	CcSEcCtD
Cefotetan—Pruritus—Docetaxel—head and neck cancer	0.00156	0.00508	CcSEcCtD
Cefotetan—Diarrhoea—Docetaxel—head and neck cancer	0.00151	0.00491	CcSEcCtD
Cefotetan—Vomiting—Docetaxel—head and neck cancer	0.0014	0.00457	CcSEcCtD
Cefotetan—Rash—Docetaxel—head and neck cancer	0.00139	0.00453	CcSEcCtD
Cefotetan—Dermatitis—Docetaxel—head and neck cancer	0.00139	0.00452	CcSEcCtD
Cefotetan—Nausea—Docetaxel—head and neck cancer	0.00131	0.00427	CcSEcCtD
